CN101757561A - Traditional Chinese medicine composition for treating chronic hepatitis and preparation method thereof - Google Patents
Traditional Chinese medicine composition for treating chronic hepatitis and preparation method thereof Download PDFInfo
- Publication number
- CN101757561A CN101757561A CN200910309217A CN200910309217A CN101757561A CN 101757561 A CN101757561 A CN 101757561A CN 200910309217 A CN200910309217 A CN 200910309217A CN 200910309217 A CN200910309217 A CN 200910309217A CN 101757561 A CN101757561 A CN 101757561A
- Authority
- CN
- China
- Prior art keywords
- grams
- gram
- radix
- chinese medicine
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a new traditional Chinese medicine composition for treating chronic hepatitis and a preparation method thereof. The traditional Chinese medicine composition mainly comprises the following Chinese medicinal herbs of dried orange peel, rhizoma cyperi, pericarpium citri reticulatae viride, radix scrophulariae, root of rehmannia, folium isatidis, root of kudzu vine, houttuynia cordata, indigo naturalis, peach kernel, red flower, radix paeoniae alba, Tuckahoe, rhizoma alismatis, oriental wormwood, desmodium, polygonum cuspidatum, root of red-rooted salvia, radix bupleuri, angelica sinensis, herba lycopi, earthworm, goldthread, felwort and root bark of the peony tree. The traditional Chinese medicine composition can be prepared into a common oral preparation according to a conventional traditional Chinese medicine preparation method. The invention can remarkably improve the symptoms of mild acratia, inappetence, abdominal distension, pain over the liver and the like of chronic persisting hepatitis, and can improve the symptoms of asthenia, poor appetite, abdominal distension, semiliquid, pain over the liver, poor complexion, poorer health, manpower reduction, hepatomegaly accompanied with haphalgesia and rap pain, and splenomegaly of the chronic active hepatitis and the symptoms of jaundice, spider angioma, liver palms, acne and the like caused by the chronic hepatitis. The invention can also improve the symptoms of long-term obvious dysfunction of liver, ALT continuous increase or repeated fluctuation, albumin reduction, globulin increase, gamma globulin or IgG increase, time extension of protrombin time, capability of positive reaction in self antibody and rheumatoid factors, capability of circulating immune complex increase, capability of addiments C3 and C4 reduction and the like, and has accurate remarkable clinical treatment effect and rapid effect taking.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of chronic hepatitis.Relating in particular to a kind of is the Chinese medicine composition and preparation method thereof of the treatment chronic hepatitis of crude drug with the Chinese herbal medicine.
Background technology
Acute viral hepatitis is not cured yet as reaching more than half a year, can develop into chronic hepatitis, part acute hepatitis B and hepatitis C patients are arranged, be chronic hepatitis when making a definite diagnosis, heavy drinking, take factors such as some drugs, some disease and also can cause chronic hepatitis.Treat timely and effectively as not taking, easily cause nerve, psychiatric system, blood system, digestive system, heart damage, and causing the multiple diseases that have a strong impact on Health and Living such as primary hepatocellular carcinoma (hcc), myocarditis, aplastic anemia, the clinical onset rate has the trend of continuous rising in recent years.
Chronic hepatitis still lacks specific Therapeutic Method at present, any medicine all never shows its curative effect to the definite of chronic hepatitis, still carrying out various test of cure at present, in order to overcome above-mentioned defective, the present invention is based on the differential diagnosis of diseases and the dialectical principle that combines of Chinese traditional treatment chronic hepatitis, treating both the principal and secondary aspects of a disease, deficiency and excess is also controlled, inside and outside logical the accent, emergency is taken in concurrently, filter out that eliminating damp-heat, detoxifcation are reduced phlegm, the natural plant of replenishing QI to invigorate the spleen,, be prepared from according to certain weight proportion according to the theory of Chinese medical science prescription.A kind of Chinese medicine composition of evident in efficacy, with low cost, treatment chronic hepatitis that toxic and side effects is minimum is provided.
Above-mentioned Chinese medicine composition of the present invention adds various conventional adjuvant required when preparing different dosage forms, for example disintegrating agent, lubricant, adhesive etc. are prepared into any oral formulations commonly used with the method for Chinese medicinal of routine, for example can be: pill, capsule, tablet, powder, granule or oral liquid etc.
Summary of the invention
Technical problem to be solved by this invention is assorted to overcome above-described shortcoming, and a kind of Chinese medicine composition of treatment chronic hepatitis of evident in efficacy, with low cost, almost non-toxic side effect is provided.
The technical problem of the desired solution of the present invention realizes by following technological approaches.
A kind of Chinese medicine composition for the treatment of chronic hepatitis of the present invention, the component of main following weight portion is formed:
Pericarpium Citri Reticulatae 1～50 gram, Rhizoma Cyperi 1～50 gram, Pericarpium Citri Reticulatae Viride 1～40 gram, Massa Medicata Fermentata 1～50 gram, Fructus Crataegi 1～40 gram, Radix Scrophulariae 1～40 gram, the Radix Rehmanniae 1～40 gram, Gypsum Fibrosum 1～50 gram, the Rhizoma Anemarrhenae 1～40 gram, Fructus Gardeniae 1～40 gram, Herba Taraxaci 1～40 gram, Folium Isatidis 1～50 gram, Radix Isatidis 1～40 gram, Radix Puerariae 1～50 gram, Herba Houttuyniae 1～50 gram, Indigo Naturalis 1～30 gram, Radix Paeoniae Rubra 1～40 gram, Semen Persicae 1～20 gram, Flos Carthami 1～20 gram, Radix Curcumae 1～30 gram, Fructus Hordei Germinatus 1～50 gram, rhizoma sparganic 1～30 gram, Rhizoma Curcumae 1～30 gram, the Radix Paeoniae Alba 1～50 gram, Cortex Magnoliae Officinalis 1～40 gram, Poria 1～50 gram, Rhizoma Alismatis 1～40 gram, Herba Artemisiae Scopariae 1～40 gram, Herba Lysimachiae 1～40 gram, Rhizoma Polygoni Cuspidati 1～40 gram, Semen Plantaginis 1～30 gram, Olibanum 1～30 gram, Myrrha 1～30 gram, Radix Salviae Miltiorrhizae 1～40 gram, Radix Bupleuri 1～40 gram, Radix Angelicae Sinensis 1～40 gram
Be preferably:
Pericarpium Citri Reticulatae 50 grams, Rhizoma Cyperi 30 grams, Pericarpium Citri Reticulatae Viride 20 grams, Massa Medicata Fermentata 30 grams, Fructus Crataegi 15 grams, Radix Scrophulariae 20 grams, the Radix Rehmanniae 20 grams, Gypsum Fibrosum 30 grams, the Rhizoma Anemarrhenae 30 grams, Fructus Gardeniae 15 grams, Herba Taraxaci 20 grams, Folium Isatidis 30 grams, Radix Isatidis 20 grams, Radix Puerariae 30 grams, Herba Houttuyniae 30 grams, Indigo Naturalis 20 grams, Radix Paeoniae Rubra 30 grams, Semen Persicae 12 grams, Flos Carthami 12 grams, Radix Curcumae 20 grams, Fructus Hordei Germinatus 30 grams, rhizoma sparganic 15 grams, Rhizoma Curcumae 15 grams, the Radix Paeoniae Alba 30 grams, Cortex Magnoliae Officinalis 15 grams, Poria 30 grams, Rhizoma Alismatis 20 grams, Herba Artemisiae Scopariae 20 grams, Herba Lysimachiae 20 grams, Rhizoma Polygoni Cuspidati 20 grams, Semen Plantaginis 20 grams, Olibanum 10 grams, Myrrha 10 grams, Radix Salviae Miltiorrhizae 20 grams, Radix Bupleuri 20 grams, Radix Angelicae Sinensis 20 grams.
The weight portion consumption of each component of Chinese medicine composition of the present invention can also be:
Herba Leonuri 1～40 gram, Herba Lycopi's 1～30 gram, Caulis Spatholobi 1～30 gram, Squama Manis 1～20 gram, Carapax Trionycis 1～30 gram, Carapax et Plastrum Testudinis 1～30 gram, Pheretima 1～30 gram, Sanguis Draxonis 1～20 gram, Radix Achyranthis Bidentatae 1～30 gram, Rhizoma Corydalis 1～30 gram, Rhizoma Curcumae Longae 1～40 gram, Fructus Amomi 1～30 gram, Semen Cassiae 1～30 gram, Herba Lophatheri 1～40 gram, Rhizoma Coptidis 1～30 gram, Radix Gentianae 1～50 gram, Cortex Moutan 1～40 gram, Radix Arnebiae (Radix Lithospermi) 1～40 gram.
Be preferably:
Herba Leonuri 20 grams, Herba Lycopi's 15 grams, Caulis Spatholobi 20 grams, Squama Manis 10 grams, Carapax Trionycis 10 grams, Carapax et Plastrum Testudinis 10 grams, Pheretima 15 grams, Sanguis Draxonis 6 grams, Radix Achyranthis Bidentatae 15 grams, Rhizoma Corydalis 20 grams, Rhizoma Curcumae Longae 20 grams, Fructus Amomi 15 grams, Semen Cassiae 20 grams, Herba Lophatheri 20 grams, Rhizoma Coptidis 15 grams, Radix Gentianae 30 grams, Cortex Moutan 20 grams, Radix Arnebiae (Radix Lithospermi) 20 grams.
Above-mentioned Chinese medicine composition of the present invention adds various conventional adjuvant required when preparing different dosage form, for example disintegrating agent, lubricant, adhesive etc. are prepared into any oral formulations commonly used with the method for Chinese medicinal of routine, for example can be pill, capsule, tablet, powder, granule or oral liquid etc.
Chinese medicine composition of the present invention is opened one's minds based on traditional Chinese medical science the five internal organs differentiation of syndromes of YIN and YANG guiding principle, in conjunction with safe one and Pu innovation theory system " ten thousand diseases ascent theory ", " the five internal organs differentiation of syndromes of YIN and YANG guiding principle ", " three-dimensional conservation regulation and control rule " and clinical treatment " pairing principle " are as instructing, take place in conjunction with disease, development and the rule that changes, classify according to the original new drug system, formation is monarch with " the five internal organs basic function is adjusted; equilibrium between yin and yang coordination side ", " the main pathogenesis of the five internal organs adjustment side " is minister, " therapy of serious disease side " is assistant, " clinical fundamental symptoms symptomatic treatment side " Chinese medicine patent medicine " original new drug system " for making.This is the important content of Thailand one and Pu (Beijing) Chinese medicine academy patent strategy.
The structure of Thailand one and Pu patent strategy is convenient to Chinese medicine and is realized standardization, scale, industrialization, modernization and industrialization.For traditional Chinese medicine development has been opened up a road that meets the Chinese medicine self-law with innovation.The used herbal raw material medicine of the present invention all can be buied from the Chinese medicine shop, and its specification meets national medical standard.
Usage and dosage: dosage of the present invention depends on concrete dosage form, factors such as patient age, body weight, health status.As guidance: for oral administration: 1) capsule: obey 2～5 every day three times at every turn, every content of dispersion 0.4 gram, warm water takes.2) tablet: every day three times, each 2～4, every content of dispersion 0.5 gram, warm water takes.3) pill: every day three times, each 5 grams, warm water takes.4) granule: every day three times.Each 5 grams, warm water takes.
The treatment that the present invention is directed to the chronic hepatitis patient is very effective, various crude drug are coordinated mutually can play together and are at utmost brought into play drug effect, can effectively improve the self-coordination ability of patient's body, significantly improve function and clinical subjective symptoms, have advantage such as have no side effect, expense is lower in addition.
The specific embodiment
Further describe the present invention by the following examples, it should be understood that these embodiment only are used for the purpose of illustration, never are limited to the present invention.
The preparation of [embodiment 1] capsule
Take by weighing each raw material by following weight portion:
Grind into after each component mixing with above-mentioned weight and incapsulate promptly after fine powder is crossed 1500 mesh sieves.
The preparation of [embodiment 2] granule
Take by weighing each raw material by following weight portion:
Each raw material of above-mentioned weight fraction is mixed, after grinding into fine powder and crossing 1500 mesh sieves, add ethanol and make adhesive, add starch and do filler, be pressed into granule.
The preparation of [embodiment 3] tablet
Take by weighing each raw material according to following weight portion:
Each raw material of above-mentioned weight portion is mixed, after grinding into fine powder and crossing 800～1200 order dusting covers, make tablet promptly.
The preparation of [embodiment 4] pill
Take by weighing each raw material according to following weight portion:
Each raw material of above-mentioned weight is mixed, grind into cross 600～1000 mesh sieves behind the fine powder after, make pill promptly.
The preparation of [embodiment 5] oral liquid
Take by weighing each raw material according to following weight portion:
Each raw material of above-mentioned weight is mixed, after three decoctions, three filtrates are mixed, filter, be concentrated into rule
Fixed concentration, put cold, the stock solution embedding, irradiation sterilization, after the check, packed products is made oral liquid promptly.
[experimental example] traditional Chinese medicine composition for treating chronic hepatitis of the present invention patient's clinical observation on the therapeutic effect experiment
One, the physical data of experimental subject: adopt Chinese medicine composition of the present invention to treat 53 routine patients altogether, wherein male 31 examples, women 22 examples; The oldest person 58 years old, the age reckling has only 5 years old.
Therapeutic Method:
Usage and dosage: adopt the prepared medicament of the embodiment of the invention, its usage and consumption are as follows: 1) capsule: obey 2～5 every day three times at every turn, and every content of dispersion 0.4 gram, warm water takes.2) tablet: every day three times, each 2～4, every content of dispersion 0.5 gram, warm water takes.3) pill: every day three times, each 5 grams, warm water takes.4) granule: every day three times.Each 5 grams, warm water takes.
The course of treatment: one month is a course of treatment, treats for 9 courses of treatment altogether.
The therapeutic evaluation standard
Cure: sign is improved fully, and the patient does not have any bad sensation, and is happy, in high spirits.
Produce effects: sign is significantly improved, and the patient does not have bad sensation substantially, and is happy, and spirit is fine.
Effectively: sign obviously changes, and random thoughts have discomfort slightly, but can accept, and mood is better, and energy is more abundant.
Invalid: sign does not have any change, and symptom such as preceding feels depressed, and lethargy is depressed.
Model case:
1, finishes certain, man, 26 years old, office worker.
The patient found the appearance yellowing of the skin before 2 years, food is received not good, is diagnosed as viral icterohepatitis through examination in hospital, and after the treatment, subjective symptoms takes a turn for the better, but abnormal liver function, continuation treatment are not disappeared in the eyes jaundice fully.Wear biopsy through liver the year before and be diagnosed as chronic hepatitis, western medicines in treatment does not all have significant curative effect, examines preceding laboratory examination: icteric index 20U, glutamate pyruvate transaminase 125U, thymol turbidity test 15U, conscious tired, pain in the right hypochondrium, tired postemphasis, complexion does not have the pool, the little Huang of sclera, thin white fur of tongue, deep-slow pulse.Take Chinese medicine composition of the present invention after 10 days, symptom makes moderate progress, and takes Chinese medicine composition of the present invention again 15, icteric index 9U, glutamate pyruvate transaminase 65U, thymol turbidity test 7U, continuous clothes Chinese medicine composition of the present invention 1 month, the appearance yellowing of the skin day by day disappears, and receives to increase, icteric index 17U, glutamate pyruvate transaminase 97U, thymol turbidity test 11U, continuous clothes Chinese medicine composition of the present invention 3 months, symptom all disappears, and once checks liver function 4 times, all belongs to normal range.
2, Jiao, woman, 15 years old.
The patient began ill toxicity anicteric hepatitis before 9 years, once certain hospital's hospitalization 1 year, also once took the treatment by Chinese herbs several months liver function persistent anomaly.So far 9 years surplus, when examining, liver function test: glutamate pyruvate transaminase 580U, the turbid 13U of Moschus moschiferous, Moschus moschiferous wadding (+++), weak, food is received general, feel sick sometimes, the urine frowziness, the complexion HUANGBAI(sic), fatigue and weak, food is received not fragrant, soreness of waist drowsiness, tongue fur are white slightly, pulse condition is heavy carefully unable.Take Chinese medicine composition of the present invention after 20 days, body is tired still to exist, receive the food still can, the check liver function: glutamate pyruvate transaminase 268U, the turbid 8U of Moschus moschiferous, the Moschus moschiferous wadding (+++), took Chinese medicine composition of the present invention again 1 month, tired symptom is got better, and food is received increase, the soreness of waist is alleviated gradually, continuous clothes Chinese medicine composition of the present invention 2 months, soreness of waist symptom greatly takes a turn for the better, and urine is normal, liver function: glutamate pyruvate transaminase is normal, the turbid 8U of Moschus moschiferous, Moschus moschiferous wadding (++), it is surplus April to obey Chinese medicine composition of the present invention again, symptom all disappears, and the every index of liver function is all normal on inspection.
3, grandson, woman, 39 years old, accounting.
The patient is conscious general weakness before 2 years, pain under the right rib, and edema of lower limbs, uncomfortable in chest, through certain examination in hospital, glutamate pyruvate transaminase 239U, the turbid 10U of Moschus moschiferous examines and is acute viral hepatitis.Through treatment, it is normal to check liver function the year before, but finds hepatitis b surface antigen positive, earlier this month twice check, all positive, other liver function tests still belong to normally, and body is tired unable when examining, and feel nervous and have a pain in the hepatic region, lower limb are swollen slightly, abdominal distention after meal, deep-thready pulse, white and thin fur.Took Chinese medicine composition of the present invention 1 month, hepatalgia is alleviated, and edema disappears, continuous clothes Chinese medicine composition of the present invention 2 months, hepatalgia greatly alleviates, anti-hepatitis B surface antigen, it is surplus March to obey Chinese medicine composition of the present invention again, and symptom all disappears, and the check hepatitis B surface antigen all belongs to negative 6 times.
4, close certain, man, 28 years old, office worker.
The patient began to suffer from acute viral hepatitis (icteric) before 5 years, the liver function obvious damage is because of the secondary diabetes then of input glucoses in a large number, be in hospital nearly 2 years, the back liver function of leaving hospital fluctuates often, and liver function is obviously unusual since nearly 1 month, examine preceding inspection: glutamate pyruvate transaminase 372U, the turbid 18U of Moschus moschiferous, fasting glucose 190mg%, glucose in urine (+++), dry mouth with bitter taste, yellowish urine, two side of body distending pains, the time epistaxis, yellow fur arranged, the limit point is red, stringy and thready pulse.Took Chinese medicine composition of the present invention 1 month, check liver function, glutamate pyruvate transaminase 120U, the turbid 6.5U of Moschus moschiferous, Moschus moschiferous wadding (-), cholesterolemia 154mg%, blood glucose 100rng%, glucose in urine (-) recovers full-time job, continuous clothes Chinese medicine composition of the present invention 3 months, two side of body distending pains greatly alleviate, conscious good, diet is normal, can adhere to work, it is surplus March to obey Chinese medicine composition of the present invention again, symptom all disappears, liver function test: glutamate pyruvate transaminase is normal, and Moschus moschiferous is turbid normal, Moschus moschiferous wadding (±), serum albumin/globulin is 4.3/2.7, blood glucose 155mg%, glucose in urine (-).
5, Pan, man, 42 years old, cadre.
Chronic hepatitis has been prolonged three years, and liver function is undesired, often has difficulty in going to sleep all night, and also dreaminess is diverse and confused after falling asleep, and the whole body is weak, lather, and right side of body dull pain, bitter taste and dryness in the mouth, the urine yellow skin, red tip of the tongue, yellow and thin fur, the little number of stringy pulse, the product that advance nourishing blood to tranquillize the mind repeatly lack imitates.Took Chinese medicine composition of the present invention 15 days, can fall asleep night, bitter taste, all illness of hypochondriac pain all subtract, continuous clothes Chinese medicine composition of the present invention 1 month, and pain disappears substantially; urine is normal; symptom is greatly taken on a new look, and it is surplus March to obey Chinese medicine composition of the present invention again, and night can intoxicated sleeping; above-mentioned symptom all disappears, and the check liver function is normal.
6, Chen, woman, 42 years old, teacher.
The patient because of abnormal liver function, did " liver is worn " before 13 years, was diagnosed as chronic hepatitis http://www.haodf.com/jibing/ganya self-induction fatigue and weak, dull pain in liver, waist soreness, yellow urine, liver function check: the turbid 16U of Moschus moschiferous, Moschus moschiferous wadding (++), albumins/globulins=4.0/3.0, glutamate pyruvate transaminase is normal, lusterless complexion, lip is light red dried slightly, and deep pulse is counted accurately, and red tongue with thin fur is greasy.Took Chinese medicine composition of the present invention 15 days, hepatalgia is alleviated, and spirit is gradually shaken, continuous clothes Chinese medicine composition of the present invention 1 month, pain disappears substantially, and the turbid test of Moschus moschiferous, the test of Moschus moschiferous wadding, glutamate pyruvate transaminase all recover normal, but poor appetite recently, sleep disintoxicated night, deep,thready and forceless pulse, and tongue is little red, it is surplus March to obey Chinese medicine composition of the present invention again, intoxicated the sleeping of energy at night, above-mentioned symptom all disappears, and the check liver function is normal.
7, the Qin, woman, 5 years old.
Found glutamate pyruvate transaminase 156U, the turbid 7U of Moschus moschiferous, Moschus moschiferous wadding (++) before 3 years during physical examination, be diagnosed as hepatitis, do not heal always, look into before examining: glutamate pyruvate transaminase 200U through " protecting the liver " treatment, the turbid 10U of Moschus moschiferous, the Moschus moschiferous wadding (+++), infant anorexia Mental fatigue, gastral cavity costalgia; yellow urine; xerostomia, red tongue with thin fur is greasy, thready and rapid pulse.Took Chinese medicine composition of the present invention 15 days, the gastral cavity costalgia is day by day alleviated, and spirit is gradually shaken, continuous clothes Chinese medicine composition of the present invention 1 month; urine is normal, check: glutamate pyruvate transaminase 80U, the turbid 8U of Moschus moschiferous; Moschus moschiferous wadding (+), and it is surplus March to obey Chinese medicine composition of the present invention again, and the check liver function recovers normal fully.
8, Zhang, man, 36 years old, driver.
Fatigue weak, hepatalgia, gastral cavity expand abdominal distention, felt sick 2 months.Look into abnormal liver function: thymol turbidity test 12U, TFT (++), glutamate pyruvate transaminase is normal, HBsAg 256U, its face is secretly sallow, and the pulse condition stringy and thready pulse is several slightly.Took Chinese medicine composition of the present invention 15 days, the gastral cavity costalgia is day by day alleviated, and spirit is gradually shaken, continuous clothes Chinese medicine composition of the present invention 1 month; urine is normal, check: glutamate pyruvate transaminase 80U, the turbid 8U of Moschus moschiferous; Moschus moschiferous wadding (+), and it is surplus March to obey Chinese medicine composition of the present invention again, and the check liver function recovers normal fully.
9, Liu, woman, 40 years old, workman.
More than 1 year, whole body is fatigue weak, inappetence, uncomfortable liver area, the time twinge is arranged, abdominal distention, dyspepsia, doctor trained in Western medicine is failed to respond to any medical treatment with hepatoprotective, liver function test: thymol turbidity test 8U, TFT (++), tongue fur is satiny, pulse condition sinks string.Took Chinese medicine composition of the present invention 15 days, hepatalgia subtracts, and abdominal distention is light, the food of receiving is promoted, continuous clothes Chinese medicine composition of the present invention 1 month, and the state of an illness takes a favorable turn, appetite is promoted, and abdominal distention obviously alleviates, and the hepatalgia sense of discomfort is eliminated, check: glutamate pyruvate transaminase 35U, the turbid 6U of Moschus moschiferous, Moschus moschiferous wadding (+), it is surplus March to obey Chinese medicine composition of the present invention again, successively 2 liver function checks are all accused normal.
Five, therapeutic outcome:
In the 53 routine cases of being accepted for medical treatment,, wherein cure 26 examples through treatment in 9 months, produce effects 10 examples, effective 13 examples, invalid 4 examples, total effective rate reaches 92%.The result shows that Chinese medicine composition of the present invention has extremely significant curative effect to treatment chronic hepatitis patient.
Claims (7)
1. Chinese medicine composition for the treatment of chronic hepatitis is characterized in that: mainly contain following bulk drugs and form:
Pericarpium Citri Reticulatae 1～50 gram, Rhizoma Cyperi 1～50 gram, Pericarpium Citri Reticulatae Viride 1～40 gram, Massa Medicata Fermentata 1～50 gram, Fructus Crataegi 1～40 gram, Radix Scrophulariae 1～40 gram, the Radix Rehmanniae 1～40 gram, Gypsum Fibrosum 1～50 gram, the Rhizoma Anemarrhenae 1～40 gram, Fructus Gardeniae 1～40 gram, Herba Taraxaci 1～40 gram, Folium Isatidis 1～50 gram, Radix Isatidis 1～40 gram, Radix Puerariae 1～50 gram, Herba Houttuyniae 1～50 gram, Indigo Naturalis 1～30 gram, Radix Paeoniae Rubra 1～40 gram, Semen Persicae 1～20 gram, Flos Carthami 1～20 gram, Radix Curcumae 1～30 gram, Fructus Hordei Germinatus 1～50 gram, rhizoma sparganic 1～30 gram, Rhizoma Curcumae 1～30 gram, the Radix Paeoniae Alba 1～50 gram, Cortex Magnoliae Officinalis 1～40 gram, Poria 1～50 gram, Rhizoma Alismatis 1～40 gram, Herba Artemisiae Scopariae 1～40 gram, Herba Lysimachiae 1～40 gram, Rhizoma Polygoni Cuspidati 1～40 gram, Semen Plantaginis 1～30 gram, Olibanum 1～30 gram, Myrrha 1～30 gram, Radix Salviae Miltiorrhizae 1～40 gram, Radix Bupleuri 1～40 gram, Radix Angelicae Sinensis 1～40 gram.
2. according to the described Chinese medicine composition of claim 1, it is characterized in that: the weight portion of each crude drug is:
Pericarpium Citri Reticulatae 50 grams, Rhizoma Cyperi 30 grams, Pericarpium Citri Reticulatae Viride 20 grams, Massa Medicata Fermentata 30 grams, Fructus Crataegi 15 grams, Radix Scrophulariae 20 grams, the Radix Rehmanniae 20 grams, Gypsum Fibrosum 30 grams, the Rhizoma Anemarrhenae 30 grams, Fructus Gardeniae 15 grams, Herba Taraxaci 20 grams, Folium Isatidis 30 grams, Radix Isatidis 20 grams, Radix Puerariae 30 grams, Herba Houttuyniae 30 grams, Indigo Naturalis 20 grams, Radix Paeoniae Rubra 30 grams, Semen Persicae 12 grams, Flos Carthami 12 grams, Radix Curcumae 20 grams, Fructus Hordei Germinatus 30 grams, rhizoma sparganic 15 grams, Rhizoma Curcumae 15 grams, the Radix Paeoniae Alba 30 grams, Cortex Magnoliae Officinalis 15 grams, Poria 30 grams, Rhizoma Alismatis 20 grams, Herba Artemisiae Scopariae 20 grams, Herba Lysimachiae 20 grams, Rhizoma Polygoni Cuspidati 20 grams, Semen Plantaginis 20 grams, Olibanum 10 grams, Myrrha 10 grams, Radix Salviae Miltiorrhizae 20 grams, Radix Bupleuri 20 grams, Radix Angelicae Sinensis 20 grams.
3. according to the described Chinese medicine composition of claim 1, wherein crude drug also has:
Herba Leonuri 1～40 gram, Herba Lycopi's 1～30 gram, Caulis Spatholobi 1～30 gram, Squama Manis 1～20 gram, Carapax Trionycis 1～30 gram, Carapax et Plastrum Testudinis 1～30 gram, Pheretima 1～30 gram, Sanguis Draxonis 1～20 gram, Radix Achyranthis Bidentatae 1～30 gram, Rhizoma Corydalis 1～30 gram, Rhizoma Curcumae Longae 1～40 gram, Fructus Amomi 1～30 gram, Semen Cassiae 1～30 gram, Herba Lophatheri 1～40 gram, Rhizoma Coptidis 1～30 gram, Radix Gentianae 1～50 gram, Cortex Moutan 1～40 gram, Radix Arnebiae (Radix Lithospermi) 1～40 gram.
4. according to the described Chinese medicine composition of claim 3, wherein the weight portion of each component is:
Herba Leonuri 20 grams, Herba Lycopi's 15 grams, Caulis Spatholobi 20 grams, Squama Manis 10 grams, Carapax Trionycis 10 grams, Carapax et Plastrum Testudinis 10 grams, Pheretima 15 grams, Sanguis Draxonis 6 grams, Radix Achyranthis Bidentatae 15 grams, Rhizoma Corydalis 20 grams, Rhizoma Curcumae Longae 20 grams, Fructus Amomi 15 grams, Semen Cassiae 20 grams, Herba Lophatheri 20 grams, Rhizoma Coptidis 15 grams, Radix Gentianae 30 grams, Cortex Moutan 20 grams, Radix Arnebiae (Radix Lithospermi) 20 grams.
5. according to claim 1,2,3 or 4 described any Chinese medicine compositions, it is characterized in that: can be prepared into any oral formulations commonly used according to the method for Chinese medicinal of routine.
6. according to the described Chinese medicine composition of claim 5, it is characterized in that: described oral formulations is pill, capsule, tablet, powder, granule or oral liquid.
7. the application of the described any Chinese medicine composition of claim 1～6 in preparation treatment chronic hepatitis medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910309217A CN101757561A (en) | 2009-11-02 | 2009-11-02 | Traditional Chinese medicine composition for treating chronic hepatitis and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910309217A CN101757561A (en) | 2009-11-02 | 2009-11-02 | Traditional Chinese medicine composition for treating chronic hepatitis and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101757561A true CN101757561A (en) | 2010-06-30 |
Family
ID=42489045
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200910309217A Pending CN101757561A (en) | 2009-11-02 | 2009-11-02 | Traditional Chinese medicine composition for treating chronic hepatitis and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101757561A (en) |
Cited By (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101926960A (en) * | 2010-08-20 | 2010-12-29 | 殷晓娜 | Orally taken traditional Chinese medicine decoction for treating cirrhosis |
| CN102100775A (en) * | 2011-01-24 | 2011-06-22 | 四川国康药业有限公司 | Anti-hepatitis-virus medicament composition as well as preparation method and application thereof |
| CN102526625A (en) * | 2012-02-14 | 2012-07-04 | 张秀兰 | Medicament for treating hepatitis B and preparation method for medicament |
| CN102552828A (en) * | 2012-03-12 | 2012-07-11 | 广州海博特医药科技有限公司 | Liver protecting medicine and preparation method thereof |
| CN102641479A (en) * | 2012-05-15 | 2012-08-22 | 张治愈 | Drug composite for treating hepatitis c |
| CN102755594A (en) * | 2012-07-19 | 2012-10-31 | 杨国兴 | Traditional Chinese medicine composition for treating acute and chronic hepatitis B and preparation method thereof |
| CN102872424A (en) * | 2012-10-19 | 2013-01-16 | 黄庆德 | Chinese herbal medicine composition for treating cirrhosis and preparation method thereof |
| CN102895449A (en) * | 2012-11-09 | 2013-01-30 | 王平 | Chinese herbal medicine composition for treating hepatosis |
| CN102940871A (en) * | 2012-12-06 | 2013-02-27 | 郑松林 | Chinese medicament for treating chronic hepatitis |
| CN103212034A (en) * | 2013-04-15 | 2013-07-24 | 刘海霞 | Chinese medicinal composition for treating chronic viral hepatitis |
| CN103520637A (en) * | 2013-09-28 | 2014-01-22 | 李海涛 | Traditional Chinese medicine composition for treatment of dampness and heat accumulation type cholecystitis |
| CN103599497A (en) * | 2013-12-05 | 2014-02-26 | 陈玉忠 | Traditional Chinese medicine for treating hepatitis B |
| CN103599481A (en) * | 2013-11-19 | 2014-02-26 | 太和县中医院 | Traditional Chinese medicine for treating active chronic hepatitis B |
| CN103736022A (en) * | 2014-01-13 | 2014-04-23 | 李绍华 | Pharmaceutical composition for treating hepatitis and liver cirrhosis |
| CN103977365A (en) * | 2014-06-06 | 2014-08-13 | 马朝富 | Traditional Chinese medicine preparation for treating hypochondriac pain and preparation method thereof |
| CN104258298A (en) * | 2014-10-15 | 2015-01-07 | 宗长兰 | Traditional Chinese medicine for treating infectious mononucleosis and preparation method of traditional Chinese medicine |
| CN104547774A (en) * | 2015-01-14 | 2015-04-29 | 孙顺新 | Traditional Chinese medicine composition for treating liver diseases, and preparation method and applications thereof |
| CN104922499A (en) * | 2015-05-20 | 2015-09-23 | 王震 | Traditional Chinese medicine for treating hepatitis |
| CN105521291A (en) * | 2014-11-27 | 2016-04-27 | 杜松 | Traditional Chinese medicine for treating spider nevus |
| CN108904525A (en) * | 2018-09-25 | 2018-11-30 | 安徽兆龙食品有限公司 | A kind of preparation method and applications of assistant activator |
-
2009
- 2009-11-02 CN CN200910309217A patent/CN101757561A/en active Pending
Cited By (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101926960B (en) * | 2010-08-20 | 2011-11-23 | 张建平 | Orally taken traditional Chinese medicine decoction for treating cirrhosis |
| CN101926960A (en) * | 2010-08-20 | 2010-12-29 | 殷晓娜 | Orally taken traditional Chinese medicine decoction for treating cirrhosis |
| CN102100775A (en) * | 2011-01-24 | 2011-06-22 | 四川国康药业有限公司 | Anti-hepatitis-virus medicament composition as well as preparation method and application thereof |
| CN102526625B (en) * | 2012-02-14 | 2013-05-08 | 张秀兰 | Medicament for treating hepatitis B and preparation method for medicament |
| CN102526625A (en) * | 2012-02-14 | 2012-07-04 | 张秀兰 | Medicament for treating hepatitis B and preparation method for medicament |
| CN102552828A (en) * | 2012-03-12 | 2012-07-11 | 广州海博特医药科技有限公司 | Liver protecting medicine and preparation method thereof |
| CN102641479A (en) * | 2012-05-15 | 2012-08-22 | 张治愈 | Drug composite for treating hepatitis c |
| CN102641479B (en) * | 2012-05-15 | 2013-08-21 | 张治愈 | Drug composite for treating hepatitis c |
| CN102755594B (en) * | 2012-07-19 | 2014-03-12 | 杨国兴 | Traditional Chinese medicine composition for treating acute and chronic hepatitis B and preparation method thereof |
| CN102755594A (en) * | 2012-07-19 | 2012-10-31 | 杨国兴 | Traditional Chinese medicine composition for treating acute and chronic hepatitis B and preparation method thereof |
| CN102872424A (en) * | 2012-10-19 | 2013-01-16 | 黄庆德 | Chinese herbal medicine composition for treating cirrhosis and preparation method thereof |
| CN102895449A (en) * | 2012-11-09 | 2013-01-30 | 王平 | Chinese herbal medicine composition for treating hepatosis |
| CN102895449B (en) * | 2012-11-09 | 2014-04-16 | 王平 | Chinese herbal medicine composition for treating hepatosis |
| CN102940871A (en) * | 2012-12-06 | 2013-02-27 | 郑松林 | Chinese medicament for treating chronic hepatitis |
| CN103212034A (en) * | 2013-04-15 | 2013-07-24 | 刘海霞 | Chinese medicinal composition for treating chronic viral hepatitis |
| CN103212034B (en) * | 2013-04-15 | 2014-07-23 | 刘海霞 | Chinese medicinal composition for treating chronic viral hepatitis |
| CN103520637A (en) * | 2013-09-28 | 2014-01-22 | 李海涛 | Traditional Chinese medicine composition for treatment of dampness and heat accumulation type cholecystitis |
| CN103520637B (en) * | 2013-09-28 | 2015-04-08 | 李海涛 | Traditional Chinese medicine composition for treatment of dampness and heat accumulation type cholecystitis |
| CN103599481A (en) * | 2013-11-19 | 2014-02-26 | 太和县中医院 | Traditional Chinese medicine for treating active chronic hepatitis B |
| CN103599481B (en) * | 2013-11-19 | 2016-04-13 | 太和县中医院 | A kind of Chinese medicine for the treatment of chronic active hepatitis B |
| CN103599497A (en) * | 2013-12-05 | 2014-02-26 | 陈玉忠 | Traditional Chinese medicine for treating hepatitis B |
| CN103599497B (en) * | 2013-12-05 | 2016-04-13 | 陈玉忠 | A kind of Chinese medicine composition for the treatment of hepatitis B |
| CN103736022B (en) * | 2014-01-13 | 2015-11-18 | 李绍华 | A kind of pharmaceutical composition for the treatment of hepatitis and liver cirrhosis |
| CN103736022A (en) * | 2014-01-13 | 2014-04-23 | 李绍华 | Pharmaceutical composition for treating hepatitis and liver cirrhosis |
| CN103977365A (en) * | 2014-06-06 | 2014-08-13 | 马朝富 | Traditional Chinese medicine preparation for treating hypochondriac pain and preparation method thereof |
| CN104258298A (en) * | 2014-10-15 | 2015-01-07 | 宗长兰 | Traditional Chinese medicine for treating infectious mononucleosis and preparation method of traditional Chinese medicine |
| CN105521291A (en) * | 2014-11-27 | 2016-04-27 | 杜松 | Traditional Chinese medicine for treating spider nevus |
| CN104547774A (en) * | 2015-01-14 | 2015-04-29 | 孙顺新 | Traditional Chinese medicine composition for treating liver diseases, and preparation method and applications thereof |
| CN104922499A (en) * | 2015-05-20 | 2015-09-23 | 王震 | Traditional Chinese medicine for treating hepatitis |
| CN108904525A (en) * | 2018-09-25 | 2018-11-30 | 安徽兆龙食品有限公司 | A kind of preparation method and applications of assistant activator |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101757561A (en) | Traditional Chinese medicine composition for treating chronic hepatitis and preparation method thereof | |
| CN101961464B (en) | Chinese medicinal composition for treating jaundice and preparation method thereof | |
| CN101757403B (en) | Traditional Chinese medicine composition for treating acute nephritis and preparation method thereof | |
| CN101816770B (en) | Chinese medicinal composition for treating diabetes and preparation method thereof | |
| CN101711849B (en) | Traditional Chinese medicine composition for treating symptoms of qi stasis, blood stasis, myoma and cyst and preparation method | |
| CN101810833B (en) | Chinese medicinal composition for treating edema and preparation method thereof | |
| CN101757540A (en) | Traditional Chinese medicine composition for treating nephrotic syndrome and preparation method thereof | |
| CN101869686B (en) | Chinese medicinal composition for treating cirrhosis | |
| CN101711851B (en) | Traditional Chinese medicine composition for treating symptoms of renal calculus and preparation method thereof | |
| CN101966320A (en) | Chinese medicinal composition for treating proliferation of mammary gland and preparation method thereof | |
| CN101703744B (en) | Chinese medicinal composition for treating palpitation and shortness of breath and preparation method thereof | |
| CN101757509B (en) | Traditional Chinese medicine composition for treating icterohepatitis and preparation method thereof | |
| CN101856474B (en) | Chinese medicinal composition for treating hypomenorrhea and preparation method thereof | |
| CN101816758B (en) | Chinese medicinal composition for treating preceded menstural cycle and preparation method thereof | |
| CN101966313A (en) | Chinese medicinal composition for treating female infertility and preparation method thereof | |
| CN101732616B (en) | Chinese medicinal composition for treating intracerebral hemorrhage and preparation method thereof | |
| CN101797352B (en) | Chinese medicinal composition for treating lassitude hypodynamia and preparation method thereof | |
| CN101816776A (en) | Chinese medicinal composition for treating delayed menstrual cycle delayed menstrual cycledelayed menstrual cycle and preparation method thereof | |
| CN101773634A (en) | Chinese medicine composition for treating abdominal distention and fullness and preparation method thereof | |
| CN101966321A (en) | Traditional Chinese medicinal composition for treating breast cancer and preparation method thereof | |
| CN101757562A (en) | Traditional Chinese medicine composition for treating mid-term malignant liver tumor symptoms and preparation method thereof | |
| CN101966319A (en) | Traditional Chinese medicinal composition for treating dizziness during menstruation and preparation method thereof | |
| CN101837112B (en) | Chinese medicinal composition for curing irregular menstrual period and preparation method thereof | |
| CN101972432A (en) | Chinese medicinal composition for treating diarrhea associated with menstruation and preparation method thereof | |
| CN101966289A (en) | Chinese medicinal composition for treating frigidity and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Open date: 20100630 |